EUVIMEDOpdag EUVIMED
Crossref

The Role of Pharmacology in the Treatment of Rare Genetic Disorders

Dr. Rebecca Moore

American Journal Of Pharmacy And Pharmacology · 2023-12-31 · 4 (6) · 1-4

DOI: 10.71465/ajpp.2825 ↗

At a glance

Journal article in American Journal Of Pharmacy And Pharmacology, published online on 2023-12-31. Written by Dr. Rebecca Moore.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Rare genetic disorders affect a small portion of the population but collectively pose significant healthcare challenges. Pharmacological advancements have introduced targeted therapies that address the molecular and genetic basis of these disorders, leading to improved outcomes and quality of life. This article discusses the current pharmacological approaches to treating rare genetic diseases, including enzyme replacement therapy, gene-based therapy, and small molecule drugs. It also explores the challenges in drug development, regulatory incentives, and future prospects for precision medicine in this domain.

Cite

APA

Moore, D. R. (2023). The Role of Pharmacology in the Treatment of Rare Genetic Disorders. American Journal Of Pharmacy And Pharmacology, 4(6), 1-4. https://doi.org/10.71465/ajpp.2825

Vancouver

Moore DR. The Role of Pharmacology in the Treatment of Rare Genetic Disorders. American Journal Of Pharmacy And Pharmacology. 2023;4(6):1-4. doi:10.71465/ajpp.2825

BibTeX
@article{Moore2023,
  author = {Moore, Dr. Rebecca},
  title = {The Role of Pharmacology in the Treatment of Rare Genetic Disorders},
  journal = {American Journal Of Pharmacy And Pharmacology},
  year = {2023},
  volume = {4},
  number = {6},
  pages = {1--4},
  doi = {10.71465/ajpp.2825}
}
Start for free →